Hemophagocytic Lymphohistiocytosis: A Case Report

• Published in: Curēus (Palo Alto, CA) CA), 2024-05, Vol.16 (5), p.e61015
• Main Authors: Costa E Silva, Teresa, Jorge Alves, Hugo, Horta Antunes, João, Noronha, Carla, Sousa Picado, Bárbara
• Format: Article
• Language: English
• Subjects: Antibiotics; Blood; Blood platelets; Bone marrow; Case reports; Cytokines; Disease; Emergency Medicine; Fever; Hematology; Hemoglobin; Hypertension; Infections; Internal Medicine; Laboratories; Leukocytes; Lymphatic system; Neutrophils; Patients; Sepsis; Triglycerides; Urine
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.61015

The hemophagocytic syndrome (HS) or hemophagocytic lymphohistiocytosis (HLH) is a syndrome with apoptosis deficiency that results in the impairment of a regulatory pathway with consequent immune and inflammatory responses. Fever, cytopenias, splenomegaly, and hemophagocytosis are cardinal signs. It may be familial or secondary to infection, autoimmunity, or neoplasia. Impaired natural killer (NK)-cell cytotoxicity is the hallmark of HLH. All genetic defects in familial HLH are related to granule-dependent cytotoxicity. The authors present a 50-year-old black female patient with a history of drepanocytosis who attended the emergency department due to fever, asthenia, lethargy, and hypogastric pain. Her laboratory workup on admission revealed severe pancytopenia. She was ultimately diagnosed with HLH due to sepsis of urinary origin, with a fatal outcome. HLH is a rare and life-threatening syndrome. The delay in its diagnosis due to the variability of the clinical and laboratory findings constitutes the main obstacle to a successful prognosis, as illustrated in this case report.